Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Other Non-Current Assets came in at $18.8 million in Q1 2026, up 376.74% year-on-year from $3.9 million in Q1 2025, and down 2.59% quarter-over-quarter from $19.3 million in Q4 2025.
Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $18.8 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 376.74% year-over-year to $18.8 million in Q1 2026; TTM through Mar 2026 was $18.8 million, a 376.74% increase from a year earlier, with the FY2025 full-year figure at $99.5 million, up 1267.18% from the prior year.
- Other Non-Current Assets declined to $18.8 million in Q1 2026 per PAHC's latest filing, from $19.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $99.5 million in Q2 2025 and bottomed at $623000.0 in Q3 2024.
- The 5-year median for Other Non-Current Assets is $8.0 million (2023), against an average of $18.2 million.
- Across the five-year window, Other Non-Current Assets plunged 98.03% in 2022 and surged 2963.56% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $7.6 million in 2022, then surged by 951.19% to $79.6 million in 2023, then tumbled by 80.2% to $15.8 million in 2024, then advanced by 22.52% to $19.3 million in 2025, then fell by 2.59% to $18.8 million in 2026.
- Per Business Quant, the three latest PAHC Other Non-Current Assets figures stand at $18.8 million (Q1 2026), $19.3 million (Q4 2025), and $19.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 18.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.82 Mn |
| Dec 31, 2025 | 19.32 Mn |
| Sep 30, 2025 | 19.09 Mn |
| Jun 30, 2025 | 99.49 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Dec 31, 2024 | 15.77 Mn |
| Sep 30, 2024 | 623,000.00 |
| Jun 30, 2024 | 7.28 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 79.64 Mn |
| Sep 30, 2023 | 7.79 Mn |
| Jun 30, 2023 | 8.03 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 8.52 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 8.77 Mn |
| Dec 31, 2021 | 5.24 Mn |
| Sep 30, 2021 | 8.53 Mn |
| Jun 30, 2021 | 72.75 Mn |